Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation
Prisma Health-Upstate
Prisma Health-Upstate
Nuvation Bio Inc.
University of Pittsburgh
Dana-Farber Cancer Institute
Gustave Roussy, Cancer Campus, Grand Paris
M.D. Anderson Cancer Center
Sanofi
European Organisation for Research and Treatment of Cancer - EORTC
Jiangsu HengRui Medicine Co., Ltd.
Telix Pharmaceuticals (Innovations) Pty Limited
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Gilead Sciences
BioMed Valley Discoveries, Inc
Hoosier Cancer Research Network
Jiangsu Simcere Pharmaceutical Co., Ltd.
Canadian Cancer Trials Group
Verastem, Inc.
Debiopharm International SA
Dana-Farber Cancer Institute
Bayer
Antengene Corporation
Akeso
Centre Leon Berard
University of Calgary
National Institutes of Health Clinical Center (CC)
Burzynski Research Institute
St Vincent's Hospital, Sydney
Columbia University
Morphotek
National Institutes of Health Clinical Center (CC)
Secretaria de Estado da Saúde
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Aduro Biotech, Inc.
University Health Network, Toronto
Stanford University
Verastem, Inc.
National Cancer Institute (NCI)
Sanofi
Dana-Farber Cancer Institute
Hospital Sant Joan de Deu
Pfizer
Amgen
M.D. Anderson Cancer Center
PharmaMar